Loratadine
Take this medicine always exactly as described in this package leaflet for the patient or as directed by your doctor or pharmacist.
Loratadyna Pylox is an antihistamine.
Loratadyna Pylox is indicated for the relief of symptoms such as: sneezing, itching,
runny nose, swelling of the mucous membranes, itching and burning of the eyes, caused by
seasonal and perennial allergic rhinitis. Loratadyna Pylox is also indicated for the relief of symptoms of
chronic idiopathic urticaria (itching, skin redness).
Loratadyna Pylox, when taken as directed, does not impair psychomotor performance, does not have a sedative effect, and does not cause drowsiness.
Before taking Loratadyna Pylox, discuss it with your doctor or pharmacist:
Treatment should be discontinued about 48 hours before the scheduled skin tests, as loratadine may cause false-negative results of these tests (this medicine may reduce or completely inhibit the skin reaction that would normally be positive).
Loratadine is contraindicated in children under 2 years of age. Administration in children from 2 years of age (see section 3).
In patients with severe liver impairment, a lower initial dose should be used, as the clearance of loratadine may be reduced in these patients. In adult patients and children with a body weight of more than 30 kg with severe liver impairment, it is recommended to start treatment with a dose of 10 mg (1 tablet) every other day, and in children with a body weight of 30 kg or less - 5 mg (in children over 6 years old - half a tablet; in children from 2 to 6 years old - in the form of syrup) every other day.
No dose adjustment is required in patients with renal impairment.
No dose adjustment is required in elderly patients.
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take.
Caution should be exercised when taking loratadine with erythromycin, ketoconazole, and cimetidine, as this may increase the concentration of loratadine in the blood.
Concomitant administration of loratadine with certain medicines that affect liver metabolism, such as CYP3A4 or CYP2D6 inhibitors, increases the concentration of loratadine in the blood, which may cause an increase in side effects.
The medicine can be taken independently of meals.
Alcohol does not enhance the effect of loratadine; however, during treatment, you should not consume alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor before taking this medicine.
Avoid taking Loratadyna Pylox during pregnancy.
Since loratadine passes into breast milk, its use is not recommended in breastfeeding women.
There are no data on the effect of Loratadyna Pylox on fertility.
In clinical trials, loratadine had no effect or an insignificant effect on the ability to drive vehicles and operate machinery. During treatment, very rarely, some people may experience drowsiness, which may impair the ability to drive vehicles and operate machinery. Therefore, caution should be exercised during treatment.
Take this medicine always exactly as described in this package leaflet for the patient or as directed by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist.
Children and adolescents
In children from 2 to 12 years of age, the dose depends on body weight:
Body weight over 30 kg: | Body weight under 30 kg: | |
10 mg (1 tablet) once a day | Children over 6 years old: | Children from 2 to 6 years old: |
5 mg (half a tablet) once a day | Not recommended for children under 6 years old; for these patients, loratadine in the form of syrup (5 mg) is recommended. |
In children over 12 years of age: 10 mg (1 tablet) once a day.
The safety and efficacy of the medicine in children under 2 years of age have not been established.
Adults
10 mg (1 tablet) once a day.
Elderly patients
No dose adjustment is required in elderly patients.
Patients with renal impairment
No dose adjustment is required in patients with renal impairment.
Patients with liver impairment
In patients with severe liver impairment, a lower initial dose should be used, as the clearance of loratadine may be reduced in these patients. In adult patients and children with a body weight of more than 30 kg with severe liver impairment, it is recommended to start treatment with a dose of 10 mg (1 tablet) every other day, and in children with a body weight of 30 kg or less - 5 mg (in children over 6 years old - half a tablet; in children from 2 to 6 years old - in the form of syrup) every other day.
If you feel that the effect of Loratadyna Pylox is too strong or too weak, consult your doctor.
If after 10 days there is no improvement or you feel worse, contact your doctor.
Oral administration.
The medicine can be taken independently of meals.
The tablet can be divided into halves.
In case of taking a higher dose than recommended, consult your doctor or pharmacist immediately.
High doses of loratadine may cause drowsiness, tachycardia (increased heart rate), and headaches. Symptomatic and supportive treatment is recommended, e.g., administration of activated charcoal, induction of vomiting, gastric lavage. Hemodialysis does not remove loratadine from the body.
There are no data indicating that loratadine causes a risk of abuse or dependence.
In case of missing a dose, take it as soon as possible. If it is already time for the next dose, do not take the missed dose. Do not take a double dose to make up for the missed dose.
In case of any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The frequency of possible side effects listed below is defined as follows:
Often:
Uncommon:
Very rare:
Frequency not known:
If any of the side effects get worse or if you experience any side effects not listed in this leaflet, tell your doctor or pharmacist.
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
There are no special precautions for storage.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Loratadyna Pylox is available in the form of white, round, flat tablets with a broken edge, with a dividing line and the number "10" embossed on one side.
Available packaging:
Blister packs of aluminum/PVC/PVDC in a cardboard box.
Pack size: 10 tablets.
Pharmaceutical Cooperative "GALENA"
Dożynkowa 10 Street
52-311 Wrocław
Poland
Phone: +48 71 710 62 01
Date of last revision of the leaflet:02.06.2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.